Article

B&L launches Stellaris vision enhancement system

The Stellaris vision enhancement system from Bausch & Lomb (B&L) is designed to meet current and future needs of the contemporary phacoemulsification surgeon, according to the company. B&L engineers reportedly designed the system based on the input of existing customers worldwide who were queried to create a list of desired new features and changes to existing technology. The result is a machine that is compact, mobile, and extremely user-friendly, provides advanced fluidics and power modulation technology, and overall yields superior control and intraoperative efficiency.

The Stellaris vision enhancement system from Bausch & Lomb (B&L) is designed to meet current and future needs of the contemporary phacoemulsification surgeon, according to the company. B&L engineers reportedly designed the system based on the input of existing customers worldwide who were queried to create a list of desired new features and changes to existing technology. The result is a machine that is compact, mobile, and extremely user-friendly, provides advanced fluidics and power modulation technology, and overall yields superior control and intraoperative efficiency.

The system allows customizable preferences for vacuum or flow-based fluidics and supports standard small-incision coaxial phaco, as well as microincision surgery using coaxial or bimanual modes. In addition, it is designed to be fully adaptable for future upgrades, eliminating the frustration of investing in new technology that too soon becomes outdated.

According to Bausch & Lomb, the system features many innovations, including a redesigned, ergonomic, ultralight titanium handpiece. In addition, it offers an 18-inch, high-resolution, touch-screen display with a large font size that is easily visible from across the operating room. The display also provides a choice of different formats, features a streaming video inlay, and shows an animated guide providing complete set-up instructions. The system's venturi pump is able to reach a vacuum level of 600 mm Hg.

For more information, visit Bausch & Lomb at Booth 1641.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
© 2025 MJH Life Sciences

All rights reserved.